Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inozyme Pharma, Inc. | 2,923,110 | reported | 01 Aug 2023 | tx 2+833,333 |
| Akouos, Inc. | 1,794,088 | reported | 30 Jun 2020 | tx 3+1,794,088−1,499,971 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Aug 2023 | PURCHASE | Inozyme Pharma, Inc. | 714,285 | 4.80 USD | |
| 01 Aug 2023 | PURCHASE | Inozyme Pharma, Inc. | 119,048 | 4.80 USD | first after silence |
| 30 Jun 2020 | PURCHASE | Akouos, Inc. | 294,117 | 17.00 USD | |
| 30 Jun 2020 | CONVERSION | Akouos, Inc. | 1,499,971 | — | |
| 30 Jun 2020 | CONVERSION | Akouos, Inc. | 1,499,971 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 01 Aug 2023.